COMMON SHARE PURCHASE AGREEMENTCommon Share Purchase Agreement • December 23rd, 2019 • Titan Medical Inc • Surgical & medical instruments & apparatus • Illinois
Contract Type FiledDecember 23rd, 2019 Company Industry JurisdictionCOMMON SHARE PURCHASE AGREEMENT (the “Agreement”), dated as of December 20, 2019 by and between TITAN MEDICAL INC., a corporation organized under the laws of Ontario (the “Company”), and ASPIRE CAPITAL FUND, LLC, an Illinois limited liability company (the “Buyer”). Capitalized terms used herein and not otherwise defined herein are defined in Section 10 hereof.
COMMON SHARE PURCHASE AGREEMENTCommon Share Purchase Agreement • August 30th, 2019 • Titan Medical Inc • Surgical & medical instruments & apparatus • Illinois
Contract Type FiledAugust 30th, 2019 Company Industry JurisdictionCOMMON SHARE PURCHASE AGREEMENT (the “Agreement”), dated as of August 29, 2019 by and between TITAN MEDICAL INC., a corporation organized under the laws of Ontario (the “Company”), and ASPIRE CAPITAL FUND, LLC, an Illinois limited liability company (the “Buyer”). Capitalized terms used herein and not otherwise defined herein are defined in Section 10 hereof.
COMMON SHARE PURCHASE AGREEMENTCommon Share Purchase Agreement • May 7th, 2019 • Aptose Biosciences Inc. • Biological products, (no disgnostic substances) • Illinois
Contract Type FiledMay 7th, 2019 Company Industry JurisdictionCOMMON SHARE PURCHASE AGREEMENT (the “Agreement”), dated as of May 7, 2019 by and between APTOSE BIOSCIENCES INC., a corporation organized under the laws of Canada (the “Company”), and ASPIRE CAPITAL FUND, LLC, an Illinois limited liability company (the “Buyer”). Capitalized terms used herein and not otherwise defined herein are defined in Section 10 hereof.
COMMON SHARE PURCHASE AGREEMENTCommon Share Purchase Agreement • May 31st, 2018 • Aptose Biosciences Inc. • Biological products, (no disgnostic substances) • Illinois
Contract Type FiledMay 31st, 2018 Company Industry JurisdictionCOMMON SHARE PURCHASE AGREEMENT (the “Agreement”), dated as of May 30, 2018 by and between APTOSE BIOSCIENCES INC., a corporation organized under the laws of Canada (the “Company”), and ASPIRE CAPITAL FUND, LLC, an Illinois limited liability company (the “Buyer”). Capitalized terms used herein and not otherwise defined herein are defined in Section 10 hereof.